Especially, considering that our families are selected based on a combination of multiple breast cancer cases, early onset of breast cancer, and ovarian cancer in the families, criteria that makes them very similar to the families with BRCA1/BRCA2 mutations. This evidence concerns the gene BRCA2 and ovarian cancer.